Skip to content
zameds

Tirzapatide (Mounjaro Kwikpen)

Tirzapatide

Eli Lilly (S.A.) (Pty) Ltd

Registration

Applicant
Eli Lilly (S.A.) (Pty) Ltd
Registrations
6

Variants

ProductStrength and formRegistrationStatusScheduleLeaflets
Mounjaro 2,5 MG kwikpen

Each 0,6 ml Solution contains: Tirzepatide 2,5 mg

2,5 mg60028260/21.13/0282RegisteredNot determinedNone
Mounjaro 5 MG kwikpen

Each 0,6 ml Solution contains: Tirzepatide 5 mg

5 mg60028360/21.13/0283RegisteredNot determinedNone
Mounjaro 7,5 MG kwikpen

Each 0,6 ml Solution contains: Tirzepatide 7,5 mg

7,5 mg60028460/21.13/0284RegisteredNot determinedNone
Mounjaro 10 MG kwikpen

Each 0,6 ml Solution contains: Tirzepatide 10 mg

10 mg60028560/21.13/0285RegisteredNot determinedNone
Mounjaro 12,5 MG kwikpen

Each 0,6 ml Solution contains: Tirzepatide 2,5 mg

12,5 mg60028660/21.13/0286RegisteredNot determinedNone
Mounjaro 15 MG kwikpen

Each 0,6 ml Solution contains: Tirzepatide 15 mg

15 mg60028760/21.13/0287RegisteredNot determinedNone

Regulatory status

This product is still scheduled by law even when this site could not determine which tier it falls under. The label carries the S number in a square border; ask a pharmacist if you need to know its schedule.

This is an informational summary of the Medicines and Related Substances Act 101 of 1965 and its 2017 General Regulations. It is not medical advice and not legal advice. Always check the medicine's label, which carries the schedule number inside a square border, or ask a pharmacist if you are unsure.

No structure available

This product's active ingredient could not be matched to a single known compound.

SAHPRA documents

SAHPRA has not published a professional information or patient information leaflet for this product.

Background

Loading...
Loading Wikipedia summary

Research articles

Loading...
Loading PubMed articles